Prolonged Vastus Lateralis Denervation After Botulinum Toxin Type A Injection

被引:5
|
作者
Dunne, John W. [1 ,2 ]
Singer, Barbara J. [1 ]
Silbert, Peter L. [1 ,2 ]
Singer, Kevin P. [1 ]
机构
[1] Univ Western Australia, Sch Surg, Ctr Musculoskeletal Studies, Perth, WA 6000, Australia
[2] Royal Perth Hosp, Dept Neurol, Perth, WA, Australia
关键词
botulinum A toxin; muscle denervation; electromyography; neuromuscular blockade; MUSCLE; DYSPORT(R); TERMINALS;
D O I
10.1002/mds.22852
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Intramuscular injection of botulinum toxin (BoNT) produces reversible blockade of neuromuscular transmission. In animal experimental models, recovery begins within four weeks and is usually complete by twelve weeks. We present evidence of prolonged denervation following BoNT injection of the vastus lateralis (VL) muscle to correct quadriceps muscle imbalance in patients with chronic anterior knee pain. Needle electromyography data were obtained from 10 subjects who had received a single BoNT treatment 5 to 19 months earlier as part of a clinical trial. Insertional and spontaneous activity, recruitment, and motor unit action potentials were examined. Clear differences between the injected and non-injected VL muscles, which correlated with the time since injection, were identified in all subjects. All 10 subjects studied with needle EMG showed evidence of persisting denervation in the BoNT-A injected VL muscle beyond the period of neuromotor recovery expected from animal experimental studies. (C) 2010 Movement Disorder Society
引用
收藏
页码:397 / 401
页数:5
相关论文
共 50 条
  • [21] Hemimasticatory Spasm Successfully Treated with Injection Botulinum Toxin
    Pandey, Sanjay
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2015, 2 (02): : 197 - 198
  • [22] CT Guided Botulinum Toxin Injection in Piriformis Syndrome
    Kim, Chul
    Park, Yong Bum
    Kim, Duk You
    ANNALS OF REHABILITATION MEDICINE-ARM, 2009, 33 (03): : 353 - 356
  • [23] Four-dimensional ultrasound biometry following botulinum toxin type A injection to the pelvic floor
    Nesbitt-Hawes, Erin M.
    Dietz, Hans Peter
    Ledger, William L.
    Abbott, Jason A.
    NEUROUROLOGY AND URODYNAMICS, 2022, 41 (01) : 375 - 382
  • [24] Evaluation and selecting indications for the treatment of improving facial morphology by masseteric injection of botulinum toxin type A
    Li Gaofeng
    Tan Jun
    Pan Bo
    Zou Bosheng
    Zhong Qian
    Liu Dongping
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2010, 63 (12) : 2026 - 2031
  • [25] Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion
    Lim, E. C. -H.
    Seet, R. C. S.
    ACTA NEUROLOGICA SCANDINAVICA, 2008, 117 (02): : 73 - 84
  • [26] Unusual delayed and prolonged arm weakness and atrophy following botulinum toxin injection for musician's cramp: case report
    Karp, Barbara I.
    Alter, Katharine
    Lehky, Tanya
    Hallett, Mark
    JOURNAL OF NEURAL TRANSMISSION, 2025,
  • [27] Botulinum toxin injection, dilution confusion: The impact of toxin diffusion on clinical practice
    Davis, Taron
    JOURNAL OF PEDIATRIC REHABILITATION MEDICINE, 2020, 13 (02) : 201 - 204
  • [28] Role of exercise testing in the functional assessment of cerebral palsy children after botulinum A toxin injection
    Massin, M
    Allington, N
    JOURNAL OF PEDIATRIC ORTHOPAEDICS, 1999, 19 (03) : 362 - 365
  • [29] Treatment of spasticity with injections of botulinum toxin type A
    Wissel, J.
    Mueller, J.
    NERVENHEILKUNDE, 2013, 32 (12) : 933 - 938
  • [30] Central Action of Botulinum Toxin Type A - Is It Possible?
    Galazka, M.
    Soszynski, D.
    Dmitruk, K.
    NEUROPHYSIOLOGY, 2015, 47 (04) : 326 - 336